Cite
MLA Citation
Masamichi Takahashi et al.. “ACT-1 Multicenter investigator-initiated registration-directed Phase 2 study of E7090 in subjects with advanced or recurrent solid tumors with fibroblast growth factor receptor (FGFR) gene alteration: FORTUNE trial.” Neuro-oncology advances, vol. 3, n.d., p. vi9. http://access.bl.uk/ark:/81055/vdc_100146751152.0x00001c